Bacterial flora in digestive disease; focus on rifaximin.3805580835
Bacterial flora in digestive disease; focus on rifaximin.
Ed. by C. Scarpignato and A. Lanas.
S. Karger, AG
Drawn from a workshop attended by Italian and Spanish gastroenterologists, this collection considers the role of the poorly absorbed antibiotic, rifaximin, in gastroenterological conditions while describing the pathogenesis and therapy of several conditions related to the microbiota Microbiota (human)
Microbial flora harbored by normal, healthy individuals. A number of microorganisms have become adapted to a particular site or ecologic niche in or on their host. of the gut. The 15 papers assess current treatment options for bowel disorders, colonic diverticular disease diverticular disease Gastroenterology The presence of multiple diverticula–prolapsed mucosa-lined intestine through the muscularis propria of the large intestine Epidemiology DD affects 5–10% of those in developed countries > age 45; 80% of those , inflammatory bowel disease inflammatory bowel disease
n. Abbr. IBD
Any of several incurable and debilitating diseases of the gastrointestinal tract characterized by inflammation and obstruction of parts of the intestine. , hepatic encephalopathy hepatic encephalopathy
See portal-systemic encephalopathy.
Also called liver encephalopathy or hepatic coma, this is a disorder in which brain function deteriorates because toxic substances, , traveler's diarrhea, and Helicobacter pylori infection. A few color photographs are provided. Originally published as Digestion, v.73, suppl.1, 2006.
([c]20062005 Book News, Inc., Portland, OR)